| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 1.09e-15 | 26 | 49 | 8 | GO:0004435 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 2.98e-15 | 29 | 49 | 8 | GO:0004629 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 8.85e-11 | 97 | 49 | 8 | GO:0008081 | |
| GeneOntologyMolecularFunction | phospholipase activity | 3.27e-10 | 114 | 49 | 8 | GO:0004620 | |
| GeneOntologyMolecularFunction | lipase activity | 1.51e-09 | 138 | 49 | 8 | GO:0016298 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 3.56e-07 | 386 | 49 | 9 | GO:0042578 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | PLCD3 PLCZ1 PLCH2 ASTE1 PLCB1 PLCD4 PLCB3 PLCB4 PLCL1 DNAJC6 | 2.16e-05 | 807 | 49 | 10 | GO:0016788 |
| GeneOntologyMolecularFunction | calcium ion binding | 4.36e-04 | 749 | 49 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | cytidine deaminase activity | 4.52e-04 | 13 | 49 | 2 | GO:0004126 | |
| GeneOntologyMolecularFunction | structural constituent of eye lens | 1.57e-03 | 24 | 49 | 2 | GO:0005212 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 2.14e-03 | 28 | 49 | 2 | GO:0000030 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 2.30e-03 | 29 | 49 | 2 | GO:0045499 | |
| GeneOntologyMolecularFunction | deaminase activity | 3.15e-03 | 34 | 49 | 2 | GO:0019239 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 3.52e-03 | 36 | 49 | 2 | GO:0016814 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 2.07e-07 | 382 | 48 | 9 | GO:0016042 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 2.65e-07 | 24 | 48 | 4 | GO:0048015 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol metabolic process | 2.64e-06 | 170 | 48 | 6 | GO:0046488 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol catabolic process | 3.17e-05 | 4 | 48 | 2 | GO:0031161 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 5.69e-05 | 90 | 48 | 4 | GO:0050688 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan | 7.91e-05 | 6 | 48 | 2 | GO:0018406 | |
| GeneOntologyBiologicalProcess | peptidyl-tryptophan modification | 7.91e-05 | 6 | 48 | 2 | GO:0018211 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation | 7.91e-05 | 6 | 48 | 2 | GO:0018103 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via tryptophan | 7.91e-05 | 6 | 48 | 2 | GO:0018317 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular DNA | 7.91e-05 | 6 | 48 | 2 | GO:0044355 | |
| GeneOntologyBiologicalProcess | clearance of foreign intracellular nucleic acids | 7.91e-05 | 6 | 48 | 2 | GO:0099046 | |
| GeneOntologyBiologicalProcess | glycerophospholipid metabolic process | 9.43e-05 | 320 | 48 | 6 | GO:0006650 | |
| GeneOntologyBiologicalProcess | DNA cytosine deamination | 2.36e-04 | 10 | 48 | 2 | GO:0070383 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 2.58e-04 | 133 | 48 | 4 | GO:0007200 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 3.31e-04 | 259 | 48 | 5 | GO:0051651 | |
| GeneOntologyBiologicalProcess | cytidine to uridine editing | 3.45e-04 | 12 | 48 | 2 | GO:0016554 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | 3.60e-04 | 410 | 48 | 6 | GO:0006644 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 3.68e-04 | 146 | 48 | 4 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 3.78e-04 | 147 | 48 | 4 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 3.98e-04 | 149 | 48 | 4 | GO:0051282 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 4.39e-04 | 153 | 48 | 4 | GO:0051208 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | 4.58e-04 | 429 | 48 | 6 | GO:0046486 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 4.64e-04 | 430 | 48 | 6 | GO:0009100 | |
| GeneOntologyBiologicalProcess | cytidine metabolic process | 4.74e-04 | 14 | 48 | 2 | GO:0046087 | |
| GeneOntologyBiologicalProcess | cytidine catabolic process | 4.74e-04 | 14 | 48 | 2 | GO:0006216 | |
| GeneOntologyBiologicalProcess | cytidine deamination | 4.74e-04 | 14 | 48 | 2 | GO:0009972 | |
| GeneOntologyBiologicalProcess | DNA deamination | 4.74e-04 | 14 | 48 | 2 | GO:0045006 | |
| GeneOntologyBiologicalProcess | egg activation | 5.46e-04 | 15 | 48 | 2 | GO:0007343 | |
| GeneOntologyBiologicalProcess | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | 6.23e-04 | 16 | 48 | 2 | GO:0045869 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside metabolic process | 6.23e-04 | 16 | 48 | 2 | GO:0046131 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside catabolic process | 6.23e-04 | 16 | 48 | 2 | GO:0046133 | |
| GeneOntologyBiologicalProcess | inositol trisphosphate metabolic process | 7.05e-04 | 17 | 48 | 2 | GO:0032957 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside catabolic process | 7.92e-04 | 18 | 48 | 2 | GO:0046135 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 8.84e-04 | 19 | 48 | 2 | GO:0045091 | |
| GeneOntologyBiologicalProcess | base conversion or substitution editing | 8.84e-04 | 19 | 48 | 2 | GO:0016553 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 9.81e-04 | 20 | 48 | 2 | GO:0039692 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 1.01e-03 | 1125 | 48 | 9 | GO:0035239 | |
| Domain | PLipase_C_Pinositol-sp_Y | 5.45e-18 | 15 | 47 | 8 | IPR001711 | |
| Domain | EF-hand_like | 5.45e-18 | 15 | 47 | 8 | PF09279 | |
| Domain | PIPLC_Y_DOMAIN | 5.45e-18 | 15 | 47 | 8 | PS50008 | |
| Domain | PI-PLC_fam | 5.45e-18 | 15 | 47 | 8 | IPR001192 | |
| Domain | PLC_EF-hand-like | 5.45e-18 | 15 | 47 | 8 | IPR015359 | |
| Domain | PI-PLC-Y | 5.45e-18 | 15 | 47 | 8 | PF00387 | |
| Domain | PLCYc | 5.45e-18 | 15 | 47 | 8 | SM00149 | |
| Domain | PI-PLC-X | 3.68e-17 | 18 | 47 | 8 | PF00388 | |
| Domain | PLCXc | 3.68e-17 | 18 | 47 | 8 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 6.35e-17 | 19 | 47 | 8 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 6.35e-17 | 19 | 47 | 8 | IPR000909 | |
| Domain | - | 8.99e-16 | 25 | 47 | 8 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 8.99e-16 | 25 | 47 | 8 | IPR017946 | |
| Domain | C2_dom | 8.09e-12 | 164 | 47 | 10 | IPR000008 | |
| Domain | C2 | 3.38e-11 | 131 | 47 | 9 | PF00168 | |
| Domain | C2 | 5.07e-11 | 137 | 47 | 9 | SM00239 | |
| Domain | C2 | 7.01e-11 | 142 | 47 | 9 | PS50004 | |
| Domain | - | 1.02e-10 | 148 | 47 | 9 | 2.60.40.150 | |
| Domain | PLC-beta_CS | 1.49e-08 | 3 | 47 | 3 | IPR009535 | |
| Domain | DUF1154 | 1.49e-08 | 3 | 47 | 3 | PF06631 | |
| Domain | - | 1.52e-08 | 261 | 47 | 9 | 1.10.238.10 | |
| Domain | EF-hand-dom_pair | 3.44e-08 | 287 | 47 | 9 | IPR011992 | |
| Domain | PLC-beta | 5.96e-08 | 4 | 47 | 3 | IPR016280 | |
| Domain | PH_dom-like | PLCD3 PLCH2 SNTG1 PLCB1 PLEKHA2 PLCD4 PLCB3 PLCB4 PLCL1 TECPR1 | 8.35e-08 | 426 | 47 | 10 | IPR011993 |
| Domain | - | 4.75e-07 | 391 | 47 | 9 | 2.30.29.30 | |
| Domain | PH | 5.67e-06 | 278 | 47 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 5.81e-06 | 279 | 47 | 7 | PS50003 | |
| Domain | PH_domain | 5.95e-06 | 280 | 47 | 7 | IPR001849 | |
| Domain | PLC-beta_C | 1.86e-05 | 3 | 47 | 2 | IPR014815 | |
| Domain | PLC-beta_C | 1.86e-05 | 3 | 47 | 2 | PF08703 | |
| Domain | PH_12 | 9.24e-05 | 6 | 47 | 2 | PF16457 | |
| Domain | EF_HAND_1 | 1.56e-04 | 204 | 47 | 5 | PS00018 | |
| Domain | EF_HAND_2 | 2.78e-04 | 231 | 47 | 5 | PS50222 | |
| Domain | APOBEC_N | 4.03e-04 | 12 | 47 | 2 | PF08210 | |
| Domain | APOBEC_N | 4.03e-04 | 12 | 47 | 2 | IPR013158 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 5.53e-04 | 14 | 47 | 2 | IPR016192 | |
| Domain | CRYSTALLIN_BETA_GAMMA | 6.37e-04 | 15 | 47 | 2 | PS50915 | |
| Domain | Crystall | 6.37e-04 | 15 | 47 | 2 | PF00030 | |
| Domain | Beta/gamma_crystallin | 6.37e-04 | 15 | 47 | 2 | IPR001064 | |
| Domain | XTALbg | 6.37e-04 | 15 | 47 | 2 | SM00247 | |
| Domain | Cytidine_deaminase-like | 8.23e-04 | 17 | 47 | 2 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 8.23e-04 | 17 | 47 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 8.23e-04 | 17 | 47 | 2 | IPR002125 | |
| Domain | G_crystallin-rel | 9.24e-04 | 18 | 47 | 2 | IPR011024 | |
| Domain | EF_Hand_1_Ca_BS | 9.70e-04 | 175 | 47 | 4 | IPR018247 | |
| Domain | EF_hand_dom | 2.72e-03 | 232 | 47 | 4 | IPR002048 | |
| Domain | Sema | 2.75e-03 | 31 | 47 | 2 | SM00630 | |
| Domain | Semap_dom | 2.75e-03 | 31 | 47 | 2 | IPR001627 | |
| Domain | Sema | 2.75e-03 | 31 | 47 | 2 | PF01403 | |
| Domain | SEMA | 2.75e-03 | 31 | 47 | 2 | PS51004 | |
| Domain | PSI | 2.93e-03 | 32 | 47 | 2 | PF01437 | |
| Domain | JMJC | 2.93e-03 | 32 | 47 | 2 | PS51184 | |
| Domain | Plexin_repeat | 2.93e-03 | 32 | 47 | 2 | IPR002165 | |
| Domain | JmjC_dom | 2.93e-03 | 32 | 47 | 2 | IPR003347 | |
| Domain | JmjC | 3.11e-03 | 33 | 47 | 2 | SM00558 | |
| Domain | PSI | 5.48e-03 | 44 | 47 | 2 | IPR016201 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 2.98e-13 | 26 | 37 | 7 | M27053 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 5.35e-13 | 28 | 37 | 7 | MM14711 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 3.20e-11 | 48 | 37 | 7 | MM14589 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 3.20e-11 | 48 | 37 | 7 | M26964 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 3.73e-11 | 49 | 37 | 7 | M40046 | |
| Pathway | WP_GPR40_PATHWAY | 2.77e-10 | 15 | 37 | 5 | M39526 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 5.04e-09 | 54 | 37 | 6 | M3896 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 2.12e-08 | 33 | 37 | 5 | M39745 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 4.09e-08 | 76 | 37 | 6 | M9052 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 1.19e-07 | 46 | 37 | 5 | M48317 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 3.31e-07 | 6 | 37 | 3 | M47548 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.40e-07 | 178 | 37 | 7 | M2890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY | 5.78e-07 | 7 | 37 | 3 | M47505 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 1.97e-06 | 10 | 37 | 3 | M47644 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.97e-06 | 10 | 37 | 3 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.71e-06 | 11 | 37 | 3 | M49033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 2.71e-06 | 11 | 37 | 3 | M47637 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 3.60e-06 | 12 | 37 | 3 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 3.60e-06 | 12 | 37 | 3 | M47628 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 4.68e-06 | 13 | 37 | 3 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.32e-05 | 18 | 37 | 3 | M47659 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 1.57e-05 | 19 | 37 | 3 | M47596 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.57e-05 | 19 | 37 | 3 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.84e-05 | 20 | 37 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.14e-05 | 21 | 37 | 3 | M47689 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 2.14e-05 | 21 | 37 | 3 | M47638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 2.14e-05 | 21 | 37 | 3 | M47542 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 2.48e-05 | 22 | 37 | 3 | M39795 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.48e-05 | 22 | 37 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.48e-05 | 22 | 37 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.84e-05 | 23 | 37 | 3 | M47676 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 3.68e-05 | 25 | 37 | 3 | M39384 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 4.15e-05 | 26 | 37 | 3 | M47557 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE | 5.21e-05 | 28 | 37 | 3 | M42536 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.21e-05 | 28 | 37 | 3 | M47508 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 6.44e-05 | 30 | 37 | 3 | M42578 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 7.11e-05 | 31 | 37 | 3 | M47554 | |
| Pathway | KEGG_GAP_JUNCTION | 8.73e-05 | 90 | 37 | 4 | M4013 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 9.99e-05 | 6 | 37 | 2 | M47960 | |
| Pathway | REACTOME_MRNA_EDITING_C_TO_U_CONVERSION | 1.40e-04 | 7 | 37 | 2 | MM15412 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 1.43e-04 | 39 | 37 | 3 | M39905 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.43e-04 | 39 | 37 | 3 | MM14496 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 1.86e-04 | 8 | 37 | 2 | MM15032 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 1.86e-04 | 8 | 37 | 2 | M27356 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 1.86e-04 | 8 | 37 | 2 | MM15100 | |
| Pathway | REACTOME_MRNA_EDITING | 2.39e-04 | 9 | 37 | 2 | MM15445 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 2.98e-04 | 10 | 37 | 2 | M1825 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 3.00e-04 | 50 | 37 | 3 | M47951 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 3.63e-04 | 11 | 37 | 2 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 3.63e-04 | 11 | 37 | 2 | MM15035 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.76e-04 | 54 | 37 | 3 | M26911 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 8.07e-04 | 70 | 37 | 3 | M3115 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 8.07e-04 | 70 | 37 | 3 | M8232 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 8.41e-04 | 71 | 37 | 3 | MM14491 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 9.49e-04 | 74 | 37 | 3 | MM15962 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 9.87e-04 | 75 | 37 | 3 | M39568 | |
| Pathway | BIOCARTA_EDG1_PATHWAY | 1.24e-03 | 20 | 37 | 2 | MM1456 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 1.36e-03 | 21 | 37 | 2 | M27409 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 1.36e-03 | 21 | 37 | 2 | MM15159 | |
| Pathway | WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES | 1.50e-03 | 22 | 37 | 2 | M45544 | |
| Pathway | BIOCARTA_EDG1_PATHWAY | 1.50e-03 | 22 | 37 | 2 | M10579 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 1.64e-03 | 23 | 37 | 2 | MM15952 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.67e-03 | 90 | 37 | 3 | M6467 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 1.94e-03 | 25 | 37 | 2 | MM15931 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 2.09e-03 | 26 | 37 | 2 | M39784 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 2.09e-03 | 26 | 37 | 2 | MM15892 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 2.13e-03 | 98 | 37 | 3 | M39830 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 2.13e-03 | 98 | 37 | 3 | M776 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 2.26e-03 | 27 | 37 | 2 | M39863 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 2.26e-03 | 27 | 37 | 2 | MM14646 | |
| Pathway | PID_CXCR4_PATHWAY | 2.26e-03 | 100 | 37 | 3 | M124 | |
| Pathway | KEGG_MELANOGENESIS | 2.32e-03 | 101 | 37 | 3 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.32e-03 | 101 | 37 | 3 | M1979 | |
| Pathway | PID_IL8_CXCR1_PATHWAY | 2.43e-03 | 28 | 37 | 2 | M252 | |
| Pathway | WP_SPHINGOLIPID_PATHWAY | 2.78e-03 | 30 | 37 | 2 | M39501 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.78e-03 | 30 | 37 | 2 | M18193 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 2.97e-03 | 31 | 37 | 2 | M213 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 3.16e-03 | 32 | 37 | 2 | M14309 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 3.16e-03 | 32 | 37 | 2 | MM15143 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 3.20e-03 | 113 | 37 | 3 | M39669 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 3.36e-03 | 115 | 37 | 3 | M9387 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 3.36e-03 | 33 | 37 | 2 | MM15027 | |
| Pathway | PID_IL8_CXCR2_PATHWAY | 3.57e-03 | 34 | 37 | 2 | M210 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 4.21e-03 | 37 | 37 | 2 | M554 | |
| Pathway | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | 4.67e-03 | 39 | 37 | 2 | M3871 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 4.69e-03 | 261 | 37 | 4 | M42565 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 4.91e-03 | 40 | 37 | 2 | M41 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 5.66e-03 | 43 | 37 | 2 | M238 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 5.82e-03 | 140 | 37 | 3 | M42572 | |
| Pathway | REACTOME_CA2_PATHWAY | 6.18e-03 | 45 | 37 | 2 | MM15040 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 7.17e-03 | 151 | 37 | 3 | M19428 | |
| Pubmed | 2.57e-16 | 18 | 50 | 7 | 1979339 | ||
| Pubmed | Expression of phospholipase C isozymes by murine B lymphocytes. | 1.25e-12 | 10 | 50 | 5 | 2033248 | |
| Pubmed | 4.74e-10 | 9 | 50 | 4 | 7589147 | ||
| Pubmed | 4.74e-10 | 9 | 50 | 4 | 10501179 | ||
| Pubmed | Genetic mapping of the human and mouse phospholipase C genes. | 1.15e-09 | 33 | 50 | 5 | 8672127 | |
| Pubmed | FRK PLCZ1 GCNT7 ADAM19 PLCB1 PLCD4 PLCB3 PLCL1 CPM PLXND1 SEMA4C | 5.74e-09 | 730 | 50 | 11 | 34857952 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 9753089 | ||
| Pubmed | Phospholipase C-β1 potentiates glucose-stimulated insulin secretion. | 1.12e-08 | 4 | 50 | 3 | 31268747 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 23006664 | ||
| Pubmed | Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. | 1.12e-08 | 4 | 50 | 3 | 9305844 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 15174099 | ||
| Pubmed | 3.28e-08 | 23 | 50 | 4 | 9730685 | ||
| Pubmed | 3.28e-08 | 23 | 50 | 4 | 9278385 | ||
| Pubmed | 3.93e-08 | 24 | 50 | 4 | 10843712 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 8739298 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 2841328 | ||
| Pubmed | 6.47e-08 | 27 | 50 | 4 | 20336759 | ||
| Pubmed | Genetic dissection of gustatory sensitivity to bitterness (sucrose octaacetate) in mice. | 9.75e-08 | 7 | 50 | 3 | 10609087 | |
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 2.69e-07 | 38 | 50 | 4 | 12482669 | |
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 23295235 | ||
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 1.26e-06 | 15 | 50 | 3 | 28578927 | |
| Pubmed | 1.87e-06 | 141 | 50 | 5 | 20056178 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22764053 | ||
| Pubmed | A locus for a human hereditary cataract is closely linked to the gamma-crystallin gene family. | 2.03e-06 | 2 | 50 | 2 | 3025877 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24475116 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 26434682 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 29339016 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 16566000 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25354700 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25354701 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15664177 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17114052 | ||
| Pubmed | 3.65e-06 | 21 | 50 | 3 | 30270038 | ||
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 6.07e-06 | 3 | 50 | 2 | 32641479 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 18177742 | ||
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 6.07e-06 | 3 | 50 | 2 | 27602762 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 23503970 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 286744 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 22691411 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 19390652 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 6.07e-06 | 3 | 50 | 2 | 22666481 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 6.07e-06 | 3 | 50 | 2 | 24577894 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 25775128 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 24725948 | ||
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 6.07e-06 | 3 | 50 | 2 | 16648136 | |
| Pubmed | Duplication and relocation of the functional DPY19L2 gene within low copy repeats. | 6.07e-06 | 3 | 50 | 2 | 16526957 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 6.07e-06 | 3 | 50 | 2 | 23533681 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 20702647 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 1541833 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 27356895 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 23315078 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 20980520 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 6.07e-06 | 3 | 50 | 2 | 25589647 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 284359 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 8687404 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 20617165 | ||
| Pubmed | Membrane targeting of C2 domains of phospholipase C-delta isoforms. | 6.07e-06 | 3 | 50 | 2 | 11706040 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 31801862 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 6.07e-06 | 3 | 50 | 2 | 39208378 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 31943071 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 6.07e-06 | 3 | 50 | 2 | 31518043 | |
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 6.07e-06 | 3 | 50 | 2 | 20566830 | |
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 6.07e-06 | 3 | 50 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 6.07e-06 | 3 | 50 | 2 | 25505062 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 31595054 | ||
| Pubmed | The gamma-crystallins and human cataracts: a puzzle made clearer. | 6.07e-06 | 3 | 50 | 2 | 10521291 | |
| Pubmed | Cloning, expression, and chaperone-like activity of human alphaA-crystallin. | 6.07e-06 | 3 | 50 | 2 | 8943244 | |
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 6.07e-06 | 3 | 50 | 2 | 24840555 | |
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 6.07e-06 | 3 | 50 | 2 | 17967065 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 20335265 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 6.07e-06 | 3 | 50 | 2 | 29593034 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 31830125 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 9765497 | ||
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 6.07e-06 | 3 | 50 | 2 | 21998583 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 24453360 | ||
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 6.07e-06 | 3 | 50 | 2 | 38115583 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 23449789 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 26639088 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 2157836 | ||
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 6.07e-06 | 3 | 50 | 2 | 35458563 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 22275865 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 6.07e-06 | 3 | 50 | 2 | 18434399 | |
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 6.07e-06 | 3 | 50 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 6.07e-06 | 3 | 50 | 2 | 18772436 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 293683 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 19150103 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 12876325 | ||
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 6.07e-06 | 3 | 50 | 2 | 18786991 | |
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 6.07e-06 | 3 | 50 | 2 | 12466850 | |
| Pubmed | Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. | 1.21e-05 | 4 | 50 | 2 | 24821801 | |
| Pubmed | Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. | 1.21e-05 | 4 | 50 | 2 | 20363737 | |
| Pubmed | Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. | 1.21e-05 | 4 | 50 | 2 | 18983852 | |
| Pubmed | Nuclear PLCs affect insulin secretion by targeting PPARγ in pancreatic β cells. | 1.21e-05 | 4 | 50 | 2 | 21974932 | |
| Pubmed | Expression and subcellular localisation of AID and APOBEC3 in adenoid and palatine tonsils. | 1.21e-05 | 4 | 50 | 2 | 29343743 | |
| Pubmed | APOBEC3 regulates keratinocyte differentiation and expression of Notch3. | 1.21e-05 | 4 | 50 | 2 | 31400166 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 3428594 | ||
| Pubmed | APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. | 1.21e-05 | 4 | 50 | 2 | 15674295 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 21873525 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 9188725 | ||
| Interaction | PLCL1 interactions | 1.94e-06 | 11 | 47 | 3 | int:PLCL1 | |
| Interaction | PLCZ1 interactions | 1.12e-05 | 19 | 47 | 3 | int:PLCZ1 | |
| Cytoband | 20p12 | 1.05e-04 | 14 | 50 | 2 | 20p12 | |
| Cytoband | 2q33.3 | 4.96e-04 | 30 | 50 | 2 | 2q33.3 | |
| Cytoband | 3q22.1 | 9.73e-04 | 42 | 50 | 2 | 3q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q33 | 1.47e-03 | 205 | 50 | 3 | chr2q33 | |
| Cytoband | 2q35 | 3.39e-03 | 79 | 50 | 2 | 2q35 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 2.66e-15 | 19 | 35 | 7 | 832 | |
| GeneFamily | Phospholipases | 1.38e-12 | 42 | 35 | 7 | 467 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 2.37e-04 | 12 | 35 | 2 | 406 | |
| GeneFamily | Beta-gamma crystallins | 3.76e-04 | 15 | 35 | 2 | 1359 | |
| GeneFamily | EF-hand domain containing | 8.17e-04 | 219 | 35 | 4 | 863 | |
| GeneFamily | SH2 domain containing | 1.63e-02 | 101 | 35 | 2 | 741 | |
| Coexpression | KRAS.AMP.LUNG_UP.V1_DN | 6.84e-06 | 142 | 49 | 5 | M2859 | |
| Coexpression | GSE29618_BCELL_VS_MDC_UP | 3.09e-05 | 194 | 49 | 5 | M4943 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN | 3.16e-05 | 195 | 49 | 5 | M9824 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 3.49e-05 | 199 | 49 | 5 | M9410 | |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 3.49e-05 | 199 | 49 | 5 | M6839 | |
| Coexpression | GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP | 3.57e-05 | 200 | 49 | 5 | M6397 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_6H_BMDC_UP | 3.57e-05 | 200 | 49 | 5 | M3943 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 176 | 50 | 5 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-06 | 177 | 50 | 5 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.63e-06 | 195 | 50 | 5 | ee8743d39996bb756f50db32748e8a902d3294b8 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.83e-06 | 198 | 50 | 5 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.83e-06 | 198 | 50 | 5 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.69e-05 | 154 | 50 | 4 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 156 | 50 | 4 | 2ba838bc864c2c1767bcab7bb4d790af96b91387 | |
| ToppCell | facs-SCAT-Fat-24m|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 162 | 50 | 4 | b824f30c723c9c7d8e8c8a8dc3f88d4eed29dd67 | |
| ToppCell | IIF-Other-HSPC|IIF / Disease, Lineage and Cell Type | 3.36e-05 | 163 | 50 | 4 | 1e0d38fbed38ac48478868a1480172a1a3f7c1b7 | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 3.69e-05 | 167 | 50 | 4 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.78e-05 | 168 | 50 | 4 | 0f736d58cb0ff042fa3ce58e36bde37b6976f8fc | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.96e-05 | 170 | 50 | 4 | 5bb577e2c4bd275fbe4ee23ff8c007b2fcb90e56 | |
| ToppCell | Healthy_donor-HSPC|Healthy_donor / disease group, cell group and cell class (v2) | 4.14e-05 | 172 | 50 | 4 | bc7549faadfc92c683c0e26bea380458706774b5 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.33e-05 | 174 | 50 | 4 | 66df78280f657978c4a568010ae7d7943869af90 | |
| ToppCell | control-Others-CD34+_GATA2+_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.73e-05 | 178 | 50 | 4 | 2120bd3e099b0b271bf079db9827a2f3eee2f909 | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 5.16e-05 | 182 | 50 | 4 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 5.16e-05 | 182 | 50 | 4 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.61e-05 | 186 | 50 | 4 | ffd4510b4435d9bf94c2ef14c629f73ab78c5d93 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.85e-05 | 188 | 50 | 4 | c613c6c7b6de8ed514253c9f9b8622c56fcc1452 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.85e-05 | 188 | 50 | 4 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.85e-05 | 188 | 50 | 4 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 189 | 50 | 4 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 189 | 50 | 4 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.97e-05 | 189 | 50 | 4 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.35e-05 | 192 | 50 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.48e-05 | 193 | 50 | 4 | e530d4349b257f2590c799bf082ed6318700c526 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.48e-05 | 193 | 50 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 194 | 50 | 4 | 5771a28a61f4d9b5479891f3224909ab003cb241 | |
| ToppCell | NS-critical-LOC-Myeloid-Macrophage|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.01e-05 | 197 | 50 | 4 | 5fb0696376a5501b7c87e0f2f5e4fff3da2903f2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 198 | 50 | 4 | a183afe4c2034323f77abfa080f359d67da35e8f | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-05 | 198 | 50 | 4 | cc5ca64749e2f4f1d373d9472824df85741702b7 | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 7.15e-05 | 198 | 50 | 4 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-MAIT|URO / Disease, condition lineage and cell class | 7.15e-05 | 198 | 50 | 4 | 75db638278d4be2b0f406cd8871058a8352c5a86 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-05 | 198 | 50 | 4 | d4d66f19df078bfc3a83d4664aaf9c7789bde1a5 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-05 | 198 | 50 | 4 | 9a77038e5db0ea757fd7ebcab294785b166ddc12 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.15e-05 | 198 | 50 | 4 | 641e7be258303bb9782d19fcf8693f317581d3b8 | |
| ToppCell | critical-Myeloid-Non-resident_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.29e-05 | 199 | 50 | 4 | 193325768b17d3123ae855317f381a01088b5dac | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 7.29e-05 | 199 | 50 | 4 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-04 | 110 | 50 | 3 | c80d1c3df75648e2c8f6832279c2acca63d76681 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-mesenchymal_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.39e-04 | 121 | 50 | 3 | 176de42c088988fe1a7838f96add26ee8a30e543 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.00e-04 | 128 | 50 | 3 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.18e-04 | 130 | 50 | 3 | 0a6b87635e650df431a88f2e6396abead84d901d | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.37e-04 | 132 | 50 | 3 | 12d2765908d5ef36f96ca3b54643a8859f807b93 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O2|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.37e-04 | 132 | 50 | 3 | e0733a41d2281d25786b9fd1da629f2e58f15b67 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.88e-04 | 137 | 50 | 3 | 6d90da42dcc06aa895f920218055068f3c76d57d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-04 | 143 | 50 | 3 | 990844ca674d30b2924c74b45bed4fdfb8463fa7 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-04 | 145 | 50 | 3 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.10e-04 | 148 | 50 | 3 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.35e-04 | 150 | 50 | 3 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-04 | 151 | 50 | 3 | 3105b8c0c401faa92e1ab8223d435b21ed45c5b7 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.60e-04 | 152 | 50 | 3 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.72e-04 | 153 | 50 | 3 | 0b3b199678d4a70b0590393568c69454bece5c14 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-04 | 154 | 50 | 3 | 1e088b0d4a44267f46a9b643f46a1aba784686b1 | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.11e-04 | 156 | 50 | 3 | 166f7b1220eaf8e1149dde260dd85a094855c54f | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.11e-04 | 156 | 50 | 3 | 5e1c5a7c9293b886920739cf766521df7f69726c | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.24e-04 | 157 | 50 | 3 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-04 | 158 | 50 | 3 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 7.51e-04 | 159 | 50 | 3 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-04 | 160 | 50 | 3 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-04 | 160 | 50 | 3 | 33050dc646762dc7e9dcc4a12c618e1ba1ce5a4d | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.65e-04 | 160 | 50 | 3 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-04 | 160 | 50 | 3 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-04 | 161 | 50 | 3 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-04 | 161 | 50 | 3 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.79e-04 | 161 | 50 | 3 | c61283c301a87bb802f6f8ce79c26067032dd7d9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.79e-04 | 161 | 50 | 3 | 9864d8b0929dacf4be7a4e97d2527ac3120ea264 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.93e-04 | 162 | 50 | 3 | e73c644ce1db34f1d390878954e86fa0b3a455a1 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.93e-04 | 162 | 50 | 3 | b115b5799137122bd60696f8ae2aebadad6cd044 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-04 | 162 | 50 | 3 | 64353d33af0e82ebb7cf2bba74d52ca0586a58fc | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 8.07e-04 | 163 | 50 | 3 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-04 | 163 | 50 | 3 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 8.07e-04 | 163 | 50 | 3 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | URO-Lymphocyte-T_NK-MAIT|URO / Disease, Lineage and Cell Type | 8.22e-04 | 164 | 50 | 3 | cb42a70433b3968caca67f7aa98ea536cd90a0bc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.22e-04 | 164 | 50 | 3 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-04 | 165 | 50 | 3 | e32697321cef424c2ad4e11ee9da3e510d5ce505 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.36e-04 | 165 | 50 | 3 | 0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 166 | 50 | 3 | e841e62cb20235d6233f78f4155fb8c0ffb1ef1b | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 166 | 50 | 3 | 3ca3ddb663644f0e7f70f9b75833bb54cd9191d3 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-04 | 166 | 50 | 3 | f751cbd01d4978ded7755874ab60504f6291afd7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.66e-04 | 167 | 50 | 3 | 0130743084dbcb20e10f96715d30961122150cbf | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.66e-04 | 167 | 50 | 3 | 29d271643f3a1718b53db77b7d093ec94225a824 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.66e-04 | 167 | 50 | 3 | 7bcae3797d3a0811e7f39885afdfd29ec517f11b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.66e-04 | 167 | 50 | 3 | c6f0209a1ad797631fdfa3efab6db6b1d3e8e315 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.81e-04 | 168 | 50 | 3 | 2781dd6b369427a94c5059b44b4c8f023f5f2988 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.81e-04 | 168 | 50 | 3 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.81e-04 | 168 | 50 | 3 | 00cff4698db14e03ca1d1b409e5ed1ad23b12615 | |
| ToppCell | mild_COVID-19-HSPC|mild_COVID-19 / disease group, cell group and cell class (v2) | 8.81e-04 | 168 | 50 | 3 | 90b33962adb77d8326dee403712118398b4d1315 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-04 | 168 | 50 | 3 | f3b7a7df54988de77dcc7066e2fc1feb9c280b13 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-04 | 169 | 50 | 3 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.96e-04 | 169 | 50 | 3 | 90c00ab30e582b0e2a2be751e1fae9024cfb9ea6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.12e-04 | 170 | 50 | 3 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-04 | 170 | 50 | 3 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-04 | 170 | 50 | 3 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.12e-04 | 170 | 50 | 3 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 170 | 50 | 3 | 7cb7ad9ab064b6ea452545d145e5b1d4090cd4c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-04 | 170 | 50 | 3 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Developing_Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 9.12e-04 | 170 | 50 | 3 | cfd7f29805b7c51666b0eaf269c36c96b8765a1a | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 170 | 50 | 3 | a78d9789c3e7c84a36e1bd380192d7aba4a4d443 | |
| Drug | norfloxacin | 5.53e-10 | 45 | 49 | 6 | CID000004539 | |
| Drug | xanthate | 1.07e-09 | 50 | 49 | 6 | CID000008823 | |
| Drug | 2-chloroadenosine | 2.16e-09 | 102 | 49 | 7 | CID000008974 | |
| Drug | chlorphentermine | 2.38e-09 | 26 | 49 | 5 | CID000010007 | |
| Drug | AC1L1G9E | 3.54e-09 | 28 | 49 | 5 | CID000003586 | |
| Drug | AC1Q6T8I | 5.12e-09 | 30 | 49 | 5 | CID000000343 | |
| Drug | cetyltrimethylammonium bromide | 7.16e-09 | 68 | 49 | 6 | CID000002681 | |
| Drug | ST271 | 1.16e-08 | 35 | 49 | 5 | CID006439072 | |
| Drug | norathyriol | 1.55e-08 | 37 | 49 | 5 | CID005281656 | |
| Drug | Triton X-100 solution | 2.91e-08 | 148 | 49 | 7 | CID000560774 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 2.99e-08 | 86 | 49 | 6 | CID000000805 | |
| Drug | compound 48/80 | 3.34e-08 | 151 | 49 | 7 | CID000104735 | |
| Drug | Lypressin | 5.36e-08 | 47 | 49 | 5 | CID000005772 | |
| Drug | sevoflurane | 9.91e-08 | 105 | 49 | 6 | CID000005206 | |
| Drug | L-quisqualic acid | 1.11e-07 | 180 | 49 | 7 | CID000001209 | |
| Drug | alpha-methylhomocysteine-thiolactone | 1.20e-07 | 55 | 49 | 5 | CID000133014 | |
| Drug | AC1Q6SH8 | 1.80e-07 | 116 | 49 | 6 | CID000000009 | |
| Drug | AC1L9K72 | 1.80e-07 | 290 | 49 | 8 | CID000446872 | |
| Drug | SKF83742 | 1.86e-07 | 6 | 49 | 3 | CID000130828 | |
| Drug | C10A | 1.86e-07 | 6 | 49 | 3 | CID000041624 | |
| Drug | (?-Fluprostenol | 2.03e-07 | 61 | 49 | 5 | CID000003391 | |
| Drug | 8-iso Misoprostol | 2.21e-07 | 62 | 49 | 5 | CID004183806 | |
| Drug | D 609 | 2.59e-07 | 64 | 49 | 5 | CID000002940 | |
| Drug | Lopac-P-178 | 3.27e-07 | 67 | 49 | 5 | CID005478935 | |
| Drug | sulprostone | 4.38e-07 | 71 | 49 | 5 | CID005312153 | |
| Drug | milrinone | 8.19e-07 | 150 | 49 | 6 | CID000004197 | |
| Drug | oxotremorine-M | 8.48e-07 | 81 | 49 | 5 | CID000004629 | |
| Drug | enantio-PAF-C16 | 8.72e-07 | 244 | 49 | 7 | CID000002499 | |
| Drug | 3-nitrocoumarin | 1.11e-06 | 10 | 49 | 3 | CID002799766 | |
| Drug | lysosphingomyelin | 1.19e-06 | 160 | 49 | 6 | CID000005263 | |
| Drug | reactive blue 2 | 1.21e-06 | 87 | 49 | 5 | CID000656725 | |
| Drug | isopetasin | 1.53e-06 | 11 | 49 | 3 | CID005318627 | |
| Drug | NSC350593 | 1.67e-06 | 269 | 49 | 7 | CID000004364 | |
| Drug | Araf-TC | 1.78e-06 | 94 | 49 | 5 | CID000100788 | |
| Drug | glycerol-3-phosphocholine | 1.82e-06 | 172 | 49 | 6 | CID000000823 | |
| Drug | ADP beta S | 1.98e-06 | 96 | 49 | 5 | CID005310996 | |
| Drug | AC1L1II7 | 2.03e-06 | 12 | 49 | 3 | CID000004589 | |
| Drug | papaverine | 2.08e-06 | 176 | 49 | 6 | CID000004680 | |
| Drug | AC1MQNLW | 3.35e-06 | 14 | 49 | 3 | CID003504628 | |
| Drug | Pl-cs | 3.37e-06 | 107 | 49 | 5 | CID006450086 | |
| Drug | spiperone | 3.53e-06 | 108 | 49 | 5 | CID000005265 | |
| Drug | sodium fluoride | 3.53e-06 | 108 | 49 | 5 | CID000005235 | |
| Drug | phosphatidate | 3.59e-06 | 432 | 49 | 8 | CID005460104 | |
| Drug | isopropyl-beta-D-thioglucoside | 3.87e-06 | 110 | 49 | 5 | CID000552632 | |
| Drug | gentamicin | 4.11e-06 | 198 | 49 | 6 | CID000003467 | |
| Drug | RHC 80267 | 4.22e-06 | 112 | 49 | 5 | CID000005063 | |
| Drug | T1 p | 4.39e-06 | 51 | 49 | 4 | CID000657023 | |
| Drug | acephylline | 4.54e-06 | 2 | 49 | 2 | CID000069550 | |
| Drug | m-3M3FBS | 5.14e-06 | 16 | 49 | 3 | CID000761523 | |
| Drug | ET-18-OCH3 | 5.92e-06 | 120 | 49 | 5 | CID000001392 | |
| Drug | Clorocruoro Hem | 6.68e-06 | 123 | 49 | 5 | CID003518809 | |
| Drug | heptachlor | 8.43e-06 | 129 | 49 | 5 | CID000003589 | |
| Drug | sapintoxin A | 8.86e-06 | 19 | 49 | 3 | CID000108085 | |
| Drug | ketanserin | 9.09e-06 | 131 | 49 | 5 | CID000003822 | |
| Drug | decanoate | 9.09e-06 | 131 | 49 | 5 | CID000002969 | |
| Drug | AC1L9ZFX | 1.01e-05 | 134 | 49 | 5 | CID000504578 | |
| Drug | pyridoxal | 1.05e-05 | 135 | 49 | 5 | CID000001050 | |
| Drug | AC1Q5THZ | 1.08e-05 | 502 | 49 | 8 | CID000001959 | |
| Drug | imipramine | 1.09e-05 | 235 | 49 | 6 | CID000003696 | |
| Drug | kinin 9 | 1.19e-05 | 363 | 49 | 7 | CID000006026 | |
| Drug | glyceraldehyde | 1.26e-05 | 140 | 49 | 5 | CID000000751 | |
| Drug | AC1L1O6Q | 1.30e-05 | 141 | 49 | 5 | CID000058035 | |
| Drug | muscarine | 1.44e-05 | 144 | 49 | 5 | CID000009308 | |
| Drug | 6-trans-leukotriene B4 | 1.45e-05 | 247 | 49 | 6 | CID000000169 | |
| Drug | fenoldopam | 1.56e-05 | 70 | 49 | 4 | CID000003340 | |
| Drug | Dethiocoenzyme A | 1.59e-05 | 147 | 49 | 5 | CID000003002 | |
| Drug | 8-isoprostaglandin E1 | 1.59e-05 | 251 | 49 | 6 | CID000000214 | |
| Drug | Sulcrate | 1.64e-05 | 148 | 49 | 5 | CID006398525 | |
| Drug | AC1NFC6P | 1.64e-05 | 148 | 49 | 5 | CID000004587 | |
| Drug | lead compounds | 1.75e-05 | 150 | 49 | 5 | CID000073212 | |
| Drug | lindane | 1.99e-05 | 154 | 49 | 5 | CID000000727 | |
| Drug | monomethyl phthalate | 2.05e-05 | 155 | 49 | 5 | CID000020392 | |
| Drug | tifomycin | 2.07e-05 | 263 | 49 | 6 | CID000000298 | |
| Drug | histamine | 2.36e-05 | 560 | 49 | 8 | CID000000774 | |
| Drug | amiodarone | 2.39e-05 | 160 | 49 | 5 | CID000002156 | |
| Drug | miltefosine | 2.40e-05 | 78 | 49 | 4 | CID000003599 | |
| Drug | 2-(aminomethyl)pyrrolidine | 2.46e-05 | 161 | 49 | 5 | CID000072032 | |
| Drug | triphosphoinositide | 2.55e-05 | 273 | 49 | 6 | CID009543520 | |
| Drug | nalidixic acid | 2.77e-05 | 277 | 49 | 6 | CID000004421 | |
| Drug | fluoride | 2.83e-05 | 278 | 49 | 6 | CID000014917 | |
| Drug | AC1Q5S71 | 3.20e-05 | 170 | 49 | 5 | CID000000501 | |
| Drug | U46619 | 3.25e-05 | 285 | 49 | 6 | CID000005618 | |
| Drug | 1,2-diglyceride | 3.67e-05 | 175 | 49 | 5 | CID000192866 | |
| Drug | Cortisporin | 3.88e-05 | 177 | 49 | 5 | CID000004454 | |
| Drug | pentoxifylline | 4.65e-05 | 304 | 49 | 6 | CID000004740 | |
| Drug | prostaglandin F2 | 4.83e-05 | 306 | 49 | 6 | CID000000160 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 5.30e-05 | 189 | 49 | 5 | CID000001413 | |
| Drug | nsc25485 | 5.38e-05 | 312 | 49 | 6 | CID000004605 | |
| Drug | allodeoxycholic acid | 5.44e-05 | 190 | 49 | 5 | CID000002987 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 5.71e-05 | 192 | 49 | 5 | 2450_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 5.71e-05 | 192 | 49 | 5 | 3114_UP | |
| Drug | prazosin | 5.85e-05 | 193 | 49 | 5 | CID000004893 | |
| Drug | 4-hydroxynonenal | 6.28e-05 | 471 | 49 | 7 | CID000001693 | |
| Drug | diisopropylfluorophosphate | 6.29e-05 | 321 | 49 | 6 | CID000005936 | |
| Drug | Sulmazole [73384-60-8]; Down 200; 14uM; PC3; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 4009_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; HL60; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 2348_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 5944_DN | |
| Drug | AC1OAGGW | 7.44e-05 | 203 | 49 | 5 | CID006857364 | |
| Drug | GF109203X | 8.78e-05 | 341 | 49 | 6 | CID000002396 | |
| Drug | NDGA | 9.96e-05 | 216 | 49 | 5 | CID000004534 | |
| Disease | cataract 2 multiple types (implicated_via_orthology) | 2.38e-06 | 2 | 46 | 2 | DOID:0110235 (implicated_via_orthology) | |
| Disease | CATARACT, AUTOSOMAL DOMINANT | 1.42e-05 | 4 | 46 | 2 | C1858679 | |
| Disease | retinal degeneration (implicated_via_orthology) | 1.87e-05 | 33 | 46 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 2.11e-05 | 215 | 46 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | CATARACT, COPPOCK-LIKE | 8.50e-05 | 9 | 46 | 2 | C1852438 | |
| Disease | Cataract, Pulverulent | 8.50e-05 | 9 | 46 | 2 | C1833118 | |
| Disease | Cataract microcornea syndrome | 8.50e-05 | 9 | 46 | 2 | C1861829 | |
| Disease | homostachydrine measurement | 1.83e-04 | 13 | 46 | 2 | EFO_0021164 | |
| Disease | Nuclear cataract | 3.58e-04 | 18 | 46 | 2 | C0392557 | |
| Disease | Nuclear non-senile cataract | 3.58e-04 | 18 | 46 | 2 | C1112705 | |
| Disease | inferior parietal cortex volume measurement | 4.00e-04 | 19 | 46 | 2 | EFO_0010307 | |
| Disease | Pseudoaphakia | 6.42e-04 | 24 | 46 | 2 | C0524524 | |
| Disease | Lens Opacities | 6.42e-04 | 24 | 46 | 2 | C1510497 | |
| Disease | Hematopoetic Myelodysplasia | 9.40e-04 | 29 | 46 | 2 | C2713368 | |
| Disease | Astigmatism | 1.08e-03 | 129 | 46 | 3 | HP_0000483 | |
| Disease | Cataract | 1.53e-03 | 37 | 46 | 2 | C0086543 | |
| Disease | Congenital small ears | 1.88e-03 | 41 | 46 | 2 | C0152423 | |
| Disease | rectum cancer | 1.97e-03 | 42 | 46 | 2 | EFO_1000657 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.00e-03 | 160 | 46 | 3 | DOID:5844 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NFVCNEGQPFMPWYK | 171 | Q96AK3 | |
| FQCVEMLSNKPWNYQ | 971 | O43683 | |
| CWENFVYNEGQQFMP | 156 | Q9UH17 | |
| YGWNNAIAMICGNVC | 201 | P49419 | |
| GMCLTYQEQCQQLWG | 516 | Q9H013 | |
| INNMWKQQCGYNPNY | 1986 | Q7Z2Y8 | |
| QQFYWLCQQNMDPSA | 921 | Q9P1A6 | |
| MCWYVHPQVLQSFQQ | 816 | Q13111 | |
| EFQRYCWNPDTGQML | 16 | P51164 | |
| MFNYAGWKNTCNNIF | 251 | Q96G23 | |
| GFCPLNSFQWRNMNT | 171 | Q2TB18 | |
| SFQGQPFIWCMLHNF | 396 | P54802 | |
| CMSYQEPQLWAGDNQ | 351 | Q5XUX1 | |
| VPMSYNNGTFCCNKW | 3051 | Q5T1H1 | |
| WCSIGVLYQQQNQPM | 321 | O15550 | |
| FRNWMNSLGVNPYIN | 401 | Q14651 | |
| CVHGNLTFWYMQNPV | 1056 | Q9Y4D7 | |
| QNVINCFPKQWFMNL | 826 | Q9Y5B6 | |
| CLSNVAFMLPWQFAQ | 331 | Q6NUT2 | |
| YQVCQVMEPNQNNWL | 71 | Q15375 | |
| SSNYMPQLFWNVGCQ | 656 | Q01970 | |
| KVQYFRFWCQQLAMP | 531 | Q96J02 | |
| SNCPQQFYNIMLECW | 456 | P42685 | |
| QQPAIFCNMVFDWPA | 41 | Q96EW2 | |
| GCWMLYEQPNYSGLQ | 41 | P07320 | |
| LQGGMQDYNYIWAQC | 261 | P14384 | |
| FQWNYVINLCGQDFP | 196 | Q6ZNI0 | |
| RNMYNWLLQNPKNVC | 146 | O75061 | |
| MCNSFQWIQYGSINN | 96 | Q9UPI3 | |
| GCWMLYERPNYQGQQ | 41 | P07315 | |
| SFIQAQYNCAWNQMP | 66 | Q9BXX0 | |
| QYNCAWNQMPCPSAL | 71 | Q9BXX0 | |
| CLSNVAFMLPWQFAQ | 141 | Q6ZN68 | |
| ANCLLWYMDNPQNLA | 36 | Q9HB19 | |
| SSNYMPQIFWNAGCQ | 631 | Q15147 | |
| PQIFWNAGCQMVSLN | 636 | Q15147 | |
| NYNPQELWNAGCQMV | 561 | Q9BRC7 | |
| RNFPVNQQIVYMGWC | 276 | Q9NSN8 | |
| SNFNPQEFWNIGCQM | 416 | Q86YW0 | |
| QEFWNIGCQMVALNF | 421 | Q86YW0 | |
| INNNPCYWGVMDKYA | 281 | Q8WXH5 | |
| SAPNWQLYFNQLQAM | 286 | Q9C0C4 | |
| QPSQNNYWKAMEGIF | 181 | Q99470 | |
| PQDFWNCGCQIVAMN | 656 | Q15111 | |
| MIQLTQNDSGFYWCG | 96 | Q6UXN2 | |
| NLNVNWYMYCPESAV | 151 | Q96DM3 | |
| NYSPQEMWNSGCQLV | 596 | Q8N3E9 | |
| SNYNPQPFWNAGCQM | 691 | O75038 | |
| QPFWNAGCQMVALNY | 696 | O75038 | |
| AYENQRWNPMGGFCE | 71 | Q7Z6L1 | |
| FNNLQWYRQNTGMGP | 51 | A0A075B6U4 | |
| SSNYMPQLFWNAGCQ | 606 | Q9NQ66 | |
| PQLFWNAGCQMVALN | 611 | Q9NQ66 | |
| QGQVHPNYFWMVSGC | 351 | Q9NYA1 | |
| QAGVQMGNACWELYC | 11 | P68366 |